Cosmology Sample Clauses

Cosmology. ‌ In this section I find the cosmological implications of the nearest order corrections coming from the deformation to general covariance. Since it is a perturbative expansion, the results when the corrections become large should be taken to be indicative rather than predictive. I restrict to a flat FLRW metric as in section 2.8, L = −a U (a) − N 2√|β | H
Cosmology. ‌ To find the cosmological dynamics, I restrict to a flat, homogeneous, and isotropic metric in proper time (N = 1). I also assume that β does not depend on the minimally coupled scalar field φ for the sake of simplicity. From (3.37), I find the ▇▇▇▇▇▇▇▇▇ equation, which can be written in two equivalent forms, R R 2 β 2 R ψ2 + H (ω H + ω′ ψ˙) = 1 ( ωψ ψ˙2 + ωφ φ˙2 + σ √|β| U ) , (3.38a) ( 1 ′ ˙)2 1 [ 1 ( ωRH + ωRψ = ωRωψ + |β| U 3 ′ ) ˙ ωRωφ √ ] R φ˙2 + σβωR
Cosmology. ‌ I restrict to an isotropic and homogeneous space to find the background cosmological dynamics, following the definitions in section 2.8. Writing the constraint as C = C(a, ψ, R) where R = R(a, ψ, p¯, π), the equations of motion are given by, a˙ = 1 ∂R ∂C , p¯˙ = −1 ( ∂C + ∂R ∂C ) , N 6a ∂p¯ ∂R N 6a ∂a ∂a ∂R ψ˙ = ∂R ∂C , π˙ = − ∂C − ∂R ∂C , N ∂π ∂R N ∂ψ ∂ψ ∂R into which I can substitute ∂C = a3√|β|. When I assume minimal coupling (ωR′ = 0, ωψ′ = 0) and time-symmetry (ξ = 0), the equations of motion become, −3σβp¯2 3 kωR σβπ2 ψ ˙ R → ωRa2 − a2 + 2ω a6 , ωR a˙ = −σβp¯√|β|, ψ = σβ π √|β|, π˙ ∂C = − , (5.61) ωψa3 = p¯˙ −1 ∂C 6a |β| a2 + a2 − 2ω √ ( σβp¯2 kωR R a6
Cosmology. 2.5.1 Studying AGN vs Starburst evolution along cosmic times
Cosmology. ‌ In 1915, ▇▇▇▇▇▇▇▇ published his equations of motion of gravity [10] Rµν − 2 gµνR = 8πGTµν , (1.1) where G is the gravitational constant (G = 6.67 × 10−11m3kg−1s−2), Rµν the Ricci tensor, R the Ricci scalar and Tµν the stress energy tensor. The left hand side of the equation is related to the metric and determines the space-time curvature of the universe, whereas the right hand side is given by the matter content of the universe. Einstein equations of motion in vacuum can be derived from the ▇▇▇▇▇▇▇▇-▇▇▇▇▇▇▇ action by varying the action with respect to the metric gµν d4x P ∫ √ M 2R where g = det(gµν). (1.1) and using the Bianchi identity, the Einstein equations imply the continuity equation ∇µT = 0 . (1.3) Modern cosmology is based on the evidence that at large scale (larger than 300 million light years [11]) the universe is homogeneous and isotropic. Different ex- periments have corroborated these assumptions. One is the identically observed temperature of the CMB, another is the distribution of galaxies around us mea- sured by the 2dF Galaxy Redshift Survey [12] (see Fig. (1.1)). Figure 1.1: Each dot is a galaxy with the Earth in the center of the map. It shows the spatial distribution of galaxies as a function of redshift from the 2dF Galaxy Redshift Survey [12]. On small scales the distribution is inhomogeneous but becomes more homogeneous on large scales. dθ
Cosmology. ‌ In 1915, ▇▇▇▇▇▇▇▇ published his equations of motion of gravity [10] Rµν − 2 gµνR = 8πGTµν , (1.1) where G is the gravitational constant (G = 6.67 × 10—11m3kg—1s—2), Rµν the Ricci tensor, R the Ricci scalar and Tµν the stress energy tensor. The left hand side of the equation is related to the metric and determines the space-time curvature of the universe, whereas the right hand side is given by the matter content of the universe. Einstein equations of motion in vacuum can be derived from the ▇▇▇▇▇▇▇▇-▇▇▇▇▇▇▇ action by varying the action with respect to the metric gµν Sg = d4x P ∫ √ M 2R where g = det(gµν). (1.1) and using the Bianchi identity, the Einstein equations imply the continuity equation ∇µT = 0 . (1.3) Modern cosmology is based on the evidence that at large scale (larger than 300 million light years [11]) the universe is homogeneous and isotropic. Different ex- periments have corroborated these assumptions. One is the identically observed temperature of the CMB, another is the distribution of galaxies around us mea- sured by the 2dF Galaxy Redshift Survey [12] (see Fig. (1.1)). Figure 1.1: Each dot is a galaxy with the Earth in the center of the map. It shows the spatial distribution of galaxies as a function of redshift from the 2dF Galaxy Redshift Survey [12]. On small scales the distribution is inhomogeneous but becomes more homogeneous on large scales. dθ (1.4) Our universe is expanding with time, galaxies move away from each other as time passes. Then we can decompose space-time in slices of constant time that are ho- mogeneous and isotropic (foliation). The metric for such a universe is called the ▇▇▇▇▇▇▇▇▇–▇▇▇▇ˆ▇▇▇▇–▇▇▇▇▇▇▇▇▇–▇▇▇▇▇▇ (FRW) metric [13, 14] = −dt + a(t) 1 − Kr2 + r

Related to Cosmology

  • Technology Discoveries, innovations, Know-How and inventions, whether patentable or not, including computer software, recognized under U.S. law as intellectual creations to which rights of ownership accrue, including, but not limited to, patents, trade secrets, maskworks and copyrights developed under this Agreement.

  • Speech Therapy This plan covers speech therapy services when provided by a qualified licensed • loss of speech or communication function; or • impairment as a result of an acute illness or injury, or an acute exacerbation of a chronic disease. Speech therapy services must relate to: • performing basic functional communication; or • assessing or treating swallowing dysfunction. See Autism Services when speech therapy services are rendered as part of the treatment of autism spectrum disorder. The amount you pay and any benefit limit will be the same whether the services are provided for habilitative or rehabilitative purposes.

  • Radiation Therapy/Chemotherapy Services This plan covers chemotherapy and radiation services. This plan covers respiratory therapy services. When respiratory services are provided in your home, as part of a home care program, durable medical equipment, supplies, and oxygen are covered as a durable medical equipment service.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Manufacturing Technology Transfer Except as provided in Section 4.3(f)(iii)(1) and Section 6.10, with respect to any Collaboration Product (or LGC Reserved Product, if applicable) for which LGC (or its Affiliate) performed CMC Development or CMC Manufacturing, if (a) Cue does not elect for LGC to perform CMC Step 2, CMC Step 3, or CMC Step 4 (or with respect to LGC Reserved Products, upon completion of CMC Step 1), or (b) upon failure of the Parties to reach agreement with respect to a Clinical Supply Agreement or a Commercial Supply Agreement or (c) [***] under this Agreement and does not cure such breach within [***] days (provided, that if such breach is not reasonably capable of cure within such [***] day period, then such cure period shall be automatically extended for an additional [***] day period as long as LGC continues to use diligent efforts to cure such breach in accordance with a reasonable cure plan and if such breach is not reasonably capable of cure within such combined [***] day period, then Cue shall reasonably consider consenting to any extension of such cure period as long as LGC continues to use diligent efforts to cure such breach in accordance with a reasonable cure plan), as applicable, then, in each case upon the written request of Cue, LGC shall use Commercially Reasonable Efforts to make a technology transfer to an Approved CMO the Manufacturing processes (including materials and such other information) but solely as is necessary to enable the Manufacture of such Collaboration Product (including the Collaboration Compound therein) (or LGC Reserved Product, including the LGC Reserved Compound therein, if applicable) by such Approved CMO to comparable biochemical structure, quality and purity as that Manufactured by LGC or its Affiliate or CMO, provided that neither Cue, LGC or any Third Party shall perform such a technology transfer to any CMO [***] without LGC’s consent, not to be unreasonably withheld, conditioned or delayed if LGC has approved the CMO to manufacture Collaboration Products (or LGC Reserved Products, if applicable). LGC shall conduct such technology transfer as soon as reasonably practicable after receiving such written notice, using good faith efforts to support supply needed to achieve timelines in the Cue Territory Development Plan (or Cue’s development plan for LGC Reserved Products, if applicable) or Cue Territory Commercialization Plan, as applicable. LGC shall conduct the first technology transfer for each Collaboration Product (or LGC Reserved Products, if applicable) [***] (provided that [***]) for a period of up to [***] months from the date Cue or its designee has provided notice it is ready to receive the technology transfer, provided, that such [***] month period [***]. After the expiration of the initial such [***] month period for a Collaboration Product (or LGC Reserved Products, if applicable), if required to complete the technology transfer to enable the Manufacture of such Collaboration Product (including the Collaboration Compound therein) (or LGC Reserved Product, including the LGC Reserved Compound therein, if applicable) by such Approved CMO to comparable biochemical structure, quality and purity as that Manufactured by LGC, LGC shall continue to provide support to Cue for up to an additional [***] period for up to [***] hours at the FTE Rate and thereafter at [***]. Thereafter, LGC will also provide [***] for such Collaboration Product (or LGC Reserved Products, if applicable). Neither Cue nor its Affiliates or Cue Collaborators shall reverse engineer any materials provided hereunder by LGC. Notwithstanding anything in this Agreement to the contrary, LGC’s CMC information may only be shared with an Approved CMO.